Inositols in the Treatment of Insulin-Mediated Diseases
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
A growing body of research is currently focused on the role of inositol isomers and in particular myo-inositol (MYO-INS) and D-chiroinositol (DCI) in the treatment of insulin resistance states. Both isomers have been shown to exert insulin-mimetic action and to lower postprandial glucose. Further, insulin resistance-related diseases were associated to derangements in inositol metabolism. Thus, the aim of this review is to provide current evidence on the potential benefits of inositol isomers (MYO-INS and DCI) in the treatment of disease associated to insulin resistance such as polycystic ovary syndrome (PCOS), gestational diabetes, and metabolic syndrome. Finally, molecular insights into inositol insulin-sensitizing effects will be covered focusing on the possible role of inositol glycans as insulin second messengers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphoinositides in cell regulation and membrane dynamics
Di Paolo, G., & De Camilli, P. (2006) · Nature · doi:10.1038/nature05185 · Cited by 2,790 · cited 2×
“membrane receptors of mitochondria and the endoplasmic reticulum, leading to an increase in calcium influx into the cytosol, which activates protein kinase C and mediates cellular responses [4].”
BackgroundDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 1×
“This derangement is responsible for androgen excess [27].”
BackgroundLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880 · cited 1×
“Patients with early stage breast cancer whowere receivingmetformin along with neoadjuvant therapy experienced a higher pathologic complete response [38].”
BackgroundOvulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary Syndrome
Nestler, J. E., Jakubowicz, D. J., Reamer, P., Gunn, R. D., & Allan, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401703 · Cited by 518 · cited 2×
“DCI has been reported to reduce insulin resistance both in lean and in obese patients with PCOS concurring to improve ovarian function and hyperandrogenism [1, 21].”
Dunn, C. J., & Peters, D. H. (1995) · Drugs · doi:10.2165/00003495-199549050-00007 · Cited by 391
Genazzani, A. D., Lanzoni, C., Ricchieri, F., & Jasonni, V. M. (2008) · Gynecological Endocrinology · doi:10.1080/09513590801893232 · Cited by 221 · cited 1×
“05) state after 12 weeks of supplementation [17].”
BackgroundEffects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials
Unfer, V., Carlomagno, G., Dante, G., & Facchinetti, F. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.650660 · Cited by 201
Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome
Iuorno, M. J., Jakubowicz, D. J., Baillargeon, J.-P., Dillon, P., Gunn, R. D., Allan, G., & Nestler, J. E. (2002) · Endocrine Practice · doi:10.4158/ep.8.6.417 · Cited by 188
Artini, P. G., Di Berardino, O. M., Papini, F., Genazzani, A. D., Simi, G., Ruggiero, M., & Cela, V. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2012.743020 · Cited by 154
Sun, T.-H., Heimark, D. B., Nguygen, T., Nadler, J. L., & Larner, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00313-3 · Cited by 144 · cited 2×
“The conversion of MYO-INS into DCI is made by NAD/NADH epimerase that is an insulin-dependent enzyme whose activity is themajor determinant of the concentrations of these two molecule in hepatic, adipose cells and muscle fibers [8].”
BackgroundZhang, H. Y., Guo, C. X., Zhu, F. F., Qu, P. P., Lin, W. J., & Xiong, J. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2568-z · Cited by 94 · cited 1×
“Obesity has been reported to worsen menstrual irregularity and increase the follicle number and serum total testosterone level [32, 33].”
BackgroundPizzo, A., Laganà, A. S., & Barbaro, L. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2013.860120 · Cited by 90 · cited 1×
“Although there is no robust consensus regarding the ideal dosage of MYO-INS and/or DCI for PCOS treatment, a combination of both MYO-INS and DCI has been suggested by the promising results from studies with their combination [47].”
ResultSelf-citationGiordano, D., Corrado, F., Santamaria, A., Quattrone, S., Pintaudi, B., Di Benedetto, A., & D'Anna, R. (2011) · Menopause · doi:10.1097/gme.0b013e3181e8e1b1 · Cited by 89
Harrison, C. L., Stepto, N. K., Hutchison, S. K., & Teede, H. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04160.x · Cited by 80
Research works printed but not linked: 36
- 10.1507/endocrj.EJ13-0423 · DOI · Paper page
- 10.1111/jog.12319 · DOI · Paper page
- 10.1111/j.1432-1033.1990.tb19297.x · DOI
- 1991, American Journal of Physiology—Cell Physiology, 260, C784, 10.1152/ajpcell.1991.260.4.C784 · DOI
- 10.1080/15604280212528 · DOI · Paper page
- 10.2337/diacare.19.1.76 · DOI
- 10.1056/nejm199008093230603 · DOI · Paper page
- 10.1073/pnas.90.13.5924 · DOI · Paper page
- 10.1056/nejmra041536 · DOI · Paper page
- 10.1038/nrendo.2013.248 · DOI
- 10.1016/j.fertnstert.2006.03.003 · DOI
- 10.1210/jc.2003-032049 · DOI · Paper page
- 10.3109/09513590.2012.685205 · DOI · Paper page
- 2007, European Review for Medical and Pharmacological Sciences, 11, 347
- 10.1007/s00404-014-3552-6 · DOI
- 10.3109/13697137.2011.631063 · DOI
- 10.1111/j.1464-5491.2011.03284.x · DOI · Paper page
- 10.2337/dc12-1371 · DOI · Paper page
- 10.1093/humrep/des463 · DOI · Paper page
- 10.1210/er.18.6.774 · DOI · Paper page
- 10.2337/db07-0275 · DOI · Paper page
- 10.1007/s10815-015-0602-3 · DOI
- 10.1159/000341823 · DOI
- 10.1210/er.2002-0015 · DOI · Paper page
- 10.1093/annonc/mdr020 · DOI
- 10.2217/fon.09.174 · DOI · Paper page
- 2015, International Journal of Clinical and Experimental Pathology, 8, 1402
- 2005, Anticancer Research, 25, 2891
- 10.1016/s1472-6483(10)60248-9 · DOI
- 10.1016/j.biochi.2013.05.011 · DOI · Paper page
- 10.1080/09513590701672405 · DOI · Paper page
- 10.3109/09513590.2014.964201 · DOI
- 10.1016/j.ejogrb.2015.09.024 · DOI · Paper page
- 10.1152/ajpendo.00479.2011 · DOI
- 10.1271/bbb.90963 · DOI · Paper page
- 10.1016/j.jnutbio.2012.01.008 · DOI
Cited by
Soy, Soy Foods and Their Role in Vegetarian Diets
Rizzo, G., & Baroni, L. (2018) · Nutrients · doi:10.3390/nu10010043 · Cited by 498
Li, C., Xing, C., Zhang, J., Zhao, H., Shi, W., & He, B. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02817-2 · Cited by 180
“Hyperinsulinemia reduces SHBG, thus increases circulating (active) androgen, stimulates pulse production in the hypothalamus, increases LH synthesis, and ultimately enhances the role of adrenocorticotropin, thus results in an increase in adrenal androgen secretion [35].”
BackgroundInositols in polycystic ovary syndrome: An overview on the advances
Facchinetti, F., Unfer, V., Dewailly, D., Kamenov, Z. A., Diamanti-Kandarakis, E., Laganà, A. S., Nestler, J. E., & Soulage, C. O. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.02.002 · Cited by 102
Self-citationPCOS and nutritional approaches: Differences between lean and obese phenotype
Barrea, L., Frias-Toral, E., Verde, L., Ceriani, F., Cucalón, G., Garcia-Velasquez, E., Moretti, D., Savastano, S., Colao, A., & Muscogiuri, G. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100123 · Cited by 86
Self-citationVitagliano, A., Saccone, G., Cosmi, E., Visentin, S., Dessole, F., Ambrosini, G., & Berghella, V. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-5005-0 · Cited by 74
Metadata
- Authors
- Muscogiuri, G., Palomba, S., Laganà, A. S., & Orio, F.
- Venue
- International Journal of Endocrinology
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-6
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- OpenAlex
- W2517001249
- Cited by
- 56
- References
- 15
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-12-04)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.